Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | 
|---|---|---|---|
| 1 | |||
| Angioedema | x | ||
| Anxiety | x | ||
| Apnoea | x | ||
| Ataxia | x | ||
| Confusional state | x | ||
| Constipation | x | ||
| Dermatitis exfoliative | x | ||
| Dizziness | x | ||
| Rash | x | ||
| Body temperature increased | x | ||
| Hallucination | x | ||
| Headache | x | ||
| Hypersensitivity | x | ||
| Hypotension | x | ||
| Nausea | x | ||
| Nervousness | x | ||
| Nightmare | x | ||
| Syncope | x | ||
| Vomiting | x | ||
| Agitation | x | ||
| CNS depression NOS | x | ||
| Hepatocellular injury | x | ||
| Hyperkinesia | x | ||
| Bradycardia | x | ||
| Somnolence | x | ||
| Hypoventilation | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Insomnia | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |